Patient group | Sharp–van der Heijde Score | ||
---|---|---|---|
Baseline | 5-year follow-up | Change from baseline to 5 years | |
*p<0.05, versus baseline; p values were determined by Wilcoxon’s signed rank test. | |||
Whole cohort (n = 134) | |||
Mean (SD) | 5.23 (7.9) | 17.68 (21.9) | 12.52 (17.9) |
Median (range) | 2 (50) | 10 (95) | 5 (89) |
Interquartile range | 0–7 | 1–22 | (0–16) |
Remission group (n = 30) | |||
Mean (SD) | 4.67 (9.65) | 9.03 (13.48) | 4.37 (7.48) |
Median (range) | 0.50 (50) | 2.5 (57) | 1.5 (32) |
Interquartile range | 0–7 | 0–14 | 0–5 |
Non-remission group (n = 104) | |||
Mean (SD) | 5.41 (7.31) | 20.30 (23.23) | 15.01 (19.43) |
Median (range) | 2 (36) | 13 (95)* | 7 (89)* |
Interquartile range | 0–7 | 3–29 | 1–19 |